×

Sign up

    ×

    Order a call

      National Cancer Institute

      33/43 Yulii Zdanovskoi St, Kyiv

      Hutsul Street, 10

      Ivano-Frankivsk,

      76006

      Write down your contact details, I will call you back and set a date and time for the reception

           

          Neuroendocrine Tumor Surgery

          Kateryna Valikhnovska, MD, surgical oncologist  >  Neuroendocrine Tumor Surgery
          Neuroendocrine tumors

          Slow growth gives time for a proper workup, but it is no reason to delay surgery when it is needed. I will review the histology with Ki-67 and your images and say whether there are grounds to consider surgery and which tests are missing.

          Kateryna Valikhnovska, MD, surgical oncologist, in the operating room before surgery
          • Ki-67 and gradewithout them the approach cannot be defined
          • Extent by organsmall bowel, appendix, rectum — different rules
          • With the mesenteryfor small bowel tumors, mesenteric lymph nodes are removed too
          • Freein-person consultation with review of your images

          Experience and why contact me

          Kateryna Valikhnovska, MD, surgical oncologist

          Kateryna Valikhnovska, MD

          Surgical oncologist · PhD in Medicine
          • 13+years of experience
          • 9,500hours in the operating room
          • 15scientific publications; PhD thesis defended in 2020

          Surgical oncologist in Kyiv. Surgeon of the first qualification category, with specialist certificates in Oncosurgery and Transplantology. Member of the Ukrainian Union of Oncology Surgeons (USSO) and the European Society of Surgical Oncology (ESSO). Awarded the Order “Scientist of the Year 2020”.

          About the surgical oncologist · Scientific works

          Surgery on all parts of the bowel

          Together with a team of surgical oncologists I perform operations for neuroendocrine tumors of the small bowel, colon and rectum, including removal of mesenteric lymph nodes and liver metastases.

          Extent by histology

          Tumor size, grade and risk factors determine whether the procedure already performed is enough or a larger operation is needed.

          I examine the whole bowel

          Small bowel tumors are often multiple and small, so during surgery I inspect and palpate the entire small bowel.

          The decision is made by a tumor board

          The approach is discussed at a multidisciplinary tumor board with oncologists, medical oncologists and radiologists.

          Direct contact with me

          Calls to my mobile number and messages come to me personally, with no call center. If I did not answer, I am in surgery: I will call back within 24 hours.

          A year of follow-up after surgery

          For a year after the operation I review your test results and images, answer questions and help with decisions about further treatment. It is a separate paid service.

          Laparoscopic surgery: the camera image on the operating room monitor
          Laparoscopic surgery: the camera image on the monitor
          The surgical team with laparoscopic instruments
          The surgical team with laparoscopic instruments
          Open surgery with binocular loupes
          Open surgery with binocular loupes — when the laparoscopic approach is not suitable

          Intestinal neuroendocrine tumors — formerly called carcinoids — mostly grow slowly and are often found incidentally: after an appendectomy, during colonoscopy or on CT. Slow growth does not mean the tumor can be left alone: some of them spread to the mesenteric lymph nodes and liver. Surgery remains the main treatment, but the extent of the operation depends on the organ, the size of the tumor and its grade. I operate together with a team of surgical oncologists; the decision is made by a tumor board.

          What is needed before surgery

          • a histopathology report with the Ki-67 index and grade — without it the approach cannot be defined;
          • somatostatin receptor PET-CT (for example, with 68Ga-DOTATATE) — to find the primary tumor and metastases of well-differentiated tumors;
          • contrast-enhanced CT of the abdomen and pelvis and liver MRI — mesentery, lymph nodes, metastases;
          • 24-hour urine 5-HIAA — for small bowel tumors and symptoms of carcinoid syndrome;
          • echocardiography — with carcinoid syndrome or high 5-HIAA levels;
          • for rectal tumors — endoscopic ultrasound or pelvic MRI.

          The disease itself, grades G1–G3 and symptoms are described on the page “Intestinal Neuroendocrine Tumors”.

          When surgery is needed

          Small bowel

          Surgery is usually recommended when the patient can tolerate it. Even with liver metastases, removal of the primary tumor with the mesentery is often considered because it reduces the risk of obstruction and impaired blood supply to the bowel.

          Appendix

          Tumors up to 1 cm removed with the appendix usually need no further surgery. Over 2 cm is an indication for right hemicolectomy; for 1–2 cm it is discussed individually based on risk factors.

          Rectum

          Grade 1 tumors up to 1 cm without invasion into the muscle layer are removed endoscopically. Over 2 cm, with muscle invasion or lymph node involvement — they are operated on like rectal cancer; for 1–2 cm — individually.

          Liver metastases

          With G1–G2 tumors the possibility of complete removal is assessed individually; cytoreduction is considered separately, in particular to control symptoms.

          Risk factors for appendiceal tumors of 1–2 cm are invasion into the mesoappendix of more than 3 mm, lymphovascular invasion, grade 2, location at the base of the appendix and a positive margin. If the tumor was found after an appendectomy, these details in the histopathology report determine whether another operation is needed.

          If surgery is not possible right now

          For slow-growing well-differentiated tumors with somatostatin receptors, somatostatin analogs are often used — injections every few weeks that slow tumor growth and relieve the symptoms of carcinoid syndrome. If the tumor progresses, radionuclide therapy and targeted drugs are used, and for neuroendocrine carcinomas — chemotherapy.

          Because these tumors often grow slowly, in selected patients the tumor board may reassess the possibility of surgery after a response to treatment.

          How the operation is performed

          For a small bowel tumor, the segment of bowel is removed together with the mesentery and lymph nodes, preserving the vessels that supply the rest of the bowel. For appendiceal tumors, when indicated, and tumors of the right colon, a right hemicolectomy is performed; for large or invasive rectal tumors — resection with the mesorectum, as for cancer.

          Patients with carcinoid syndrome are given a somatostatin analog before surgery to reduce the risk of carcinoid crisis — sharp blood pressure swings, bronchospasm and arrhythmias during the procedure. When the tumor location and extent of resection allow it, the operation is performed laparoscopically — through a few small incisions.

          Hospital stay, recovery and follow-up

          Recovery follows the enhanced recovery (ERAS) protocol: early mobilization, early eating, controlled pain relief. After resection of a segment of small bowel or a right hemicolectomy, digestion usually recovers, although changes in bowel habits are possible; after removal of the last part of the ileum, vitamin B12 levels are monitored.

          Adjuvant chemotherapy after radical removal of a G1–G2 tumor is usually not needed. In patients receiving somatostatin analogs long term, the gallbladder is monitored because these drugs promote gallstone formation.

          Follow-up is usually long-term, because recurrences can appear late. The exception is completely removed G1 tumors of the appendix or rectum under 1 cm without adverse features. CT or MRI is used, and when indicated somatostatin receptor PET-CT and 5-HIAA; the intervals are set by the doctor.

          Risks and complications

          Risks are what patients ask about least often, although they are the most important thing to discuss before surgery. The main ones are:

          • carcinoid crisis — in patients with carcinoid syndrome; this is why a somatostatin analog is given before surgery;
          • anastomotic leak — when the join in the bowel does not heal;
          • bleeding during or after surgery;
          • infection and general surgical complications, including thrombosis.

          The likelihood of each depends on the organ, the extent of surgery and general condition. I will explain the risks in your particular case at the consultation.

          What the cost depends on

          The cost depends on the organ and extent of surgery, the approach, whether liver metastases are removed, the number of days in the hospital and the tests. The exact amount is named once the treatment plan has been defined. The payment can be split into parts — installments are available. The in-person consultation is free. More details are on the page “Cost of Surgery: What It Depends On”.

          What documents are needed and how to book

          • the histopathology and immunohistochemistry report with the Ki-67 index and grade, tissue blocks and slides;
          • CT, MRI and PET-CT discs with the reports;
          • the operative or endoscopic removal report, if the tumor has already been removed;
          • 5-HIAA and chromogranin A results and echocardiography results, if performed;
          • a list of the medications you take, including somatostatin analogs.

          Book a consultation by phone or through the form. If you are from another city, send the documents in advance — how to do this is described on the page “Online Oncologist Consultation”.

          Frequently asked questions

          The tumor was found after an appendectomy. Is another operation needed?

          It depends on the histopathology report: size, grade, invasion into the mesoappendix and lymphovascular invasion. For a tumor up to 1 cm without risk factors, appendectomy is usually enough; for tumors over 2 cm a right hemicolectomy is recommended, and for 1–2 cm the decision is made individually.

          How much does neuroendocrine tumor surgery cost?

          The cost depends on the organ, the extent of surgery, the approach, the days in the hospital and the tests. The exact amount is named after the consultation, once the treatment plan has been defined. The in-person consultation is free, and installments are available.

          Is surgery worthwhile if there are already liver metastases?

          Often, yes. For small bowel tumors, removing the primary tumor with the mesentery reduces the risk of obstruction even with metastases. Whether liver metastases from G1–G2 tumors can be removed is assessed individually.

          Is chemotherapy needed after surgery?

          After radical removal of G1–G2 tumors — usually not. Chemotherapy is used for G3 tumors and neuroendocrine carcinomas.

          Why somatostatin receptor PET-CT?

          It is a highly sensitive method of finding the primary tumor and metastases of well-differentiated tumors. It also shows whether the tumor could be treated with drugs that act through somatostatin receptors.

          How long is follow-up after surgery?

          Usually long-term, because recurrences can appear late; after complete removal of G1 tumors of the appendix or rectum under 1 cm without adverse features, follow-up is minimal. The interval between tests is set by the doctor based on the grade and stage of the tumor.

          Surgery is the third of six steps

          Surgery is preceded by a review of your documents and a tumor board, and followed by recovery, a decision on further treatment and a year of follow-up.

          1. Step 1

            Review of the clinical situation: all examination materials, CT and MRI discs, medical history.

          2. Step 2

            Discussion of the case by a multidisciplinary team with oncologists, medical oncologists and radiologists.

          3. Step 3 you are here

            Surgery according to international protocols together with a team of surgical oncologists.

          4. Step 4

            The early postoperative period under the ERAS enhanced recovery protocol.

          5. Step 5

            Defining further management; drug treatment when indicated.

          6. Step 6

            Advisory support for a year: monitoring test results and reviewing CT and MRI discs.

          Дізнайтеся ціни на високотехнологічні операції

          Заповніть форму — і я зв’яжуся з вами щодо консультації